Steve Pacelli Appointed CEO of Epitel, Inc.
Pacelli, A Former Executive of Dexcom, Inc., Will Lead Epitel Into Its Next Phase of Growth
SALT LAKE CITY–(BUSINESS WIRE)–Epitel, Inc., a leader in AI technologies for patient-focused brain health solutions, is pleased to announce that Steve Pacelli has been appointed as the company’s new Chief Executive Officer. Pacelli, a seasoned executive with a track record of success in the medical technology industry, brings a wealth of experience and leadership to Epitel as it further drives its mission to transform the lives of individuals affected by seizures and other neurological conditions. As the executive team expands, Mark Lehmkuhle, the company’s current CEO and founder, will transition to the role of Chief Technology Officer.
